The effectiveness of gabapentin in patients with chronic radiculopathy
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
This study was carried out to determine the efficacy of gabapentin in patients with radiculopathy. Fifty patients (32 women, 18 men) with lumbosciatalgia secondary to L5 or S1 radiculopathy were evaluated. MRI showed L4-5 and/or L5-S1 bulging and/or protrusion without significant spinal stenosis. Baseline assessments for each patient included a standard neurological examination and radiological investigation. The patients were randomly assigned into two groups: group 1 was treated with oral gabapentin from a total of 900 mg per day up a total of 3600 mg per day divided in 3 doses; group 2 received placebo for the 8-week trial period. In group 1 we observed statistically significant improvement in pain at rest (p < 0.001), motor function (p < 0.01), limitation of spinal flexion (p < 0.001), straight leg raising test (p < 0.001) and sensory function (p < 0.001). Stretch reflexes instead did not significantly change. In group 2 we observed significant improvement in all clinical parameters, muscle strength and stretch reflexes excluded. The results of group 1 were significantly better than those of group 2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This study focuses specifically on the use of gabapentin and pregabalin for pain associated with acute sciatica since the evidence on their use is limited.”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [20]
In the citing paper
“Regarding gabapentin trials, one study compared this gabapentinoid with placebo,20 one with no matched intervention,31 and one compared tramadol versus gabapentin plus tramadol.30”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [20]
In the citing paper
“Similarly, the risk for blinding of outcome assessment (detection bias) was low or unclear for all but three studies, which were rated as high risk of bias in this item.20, 31, 32”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [20]
In the citing paper
“To our knowledge regarding their use on sciatica, pain relief only has been reported in one trial comparing gabapentin with placebo20 and in no one of those investigating pregabalin.21”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [20]
In the citing paper
“Assessment of other potential sources of bias gave a low risk of bias for four studies.20, 21, 30, 31 Three were rated as unclear risk of bias28, 29, 32 and one was rated as high risk of bias27 due to a run-in period, where placebo respondents and pregabalin non-respondents were eliminated.”
From A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain (2022) · cites this paper as [20]
Citations
Cites
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
Central post-stroke pain — a controlled trial of amitriptyline and carbamazepine
Leijon, G., & Boivie, J. (1989) · Pain · doi:10.1016/0304-3959(89)90108-5 · Cited by 392
The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain
Hunter, J. C., Gogas, K. R., Hedley, L. R., Jacobson, L. O., Kassotakis, L., Thompson, J., & Fontana, D. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00070-8 · Cited by 310
Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies
Suman-Chauhan, N., Webdale, L., Hill, D. R., & Woodruff, G. N. (1993) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(93)90155-3 · Cited by 225
Reflex sympathetic dystrophy treated with gabapentin
Mellick, G. A., & Mellick, L. B. (1997) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(97)90020-4 · Cited by 204
Gabapentin inhibits calcium currents in isolated rat brain neurons
Stefani, A., Spadoni, F., & Bernardi, G. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(97)00189-5 · Cited by 201
(1992) · APS Journal · doi:10.1016/1058-9139(92)90082-n · Cited by 180
Anticonvulsants (Antineuropathics) for Neuropathic Pain Syndromes
Bačkonja, M.-M. (2000) · Clinical Journal of Pain · doi:10.1097/00002508-200006001-00012 · Cited by 153
Gabapentin use in neuropathic pain syndromes
Nicholson, B. D. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.0006a.x · Cited by 152
Research works printed but not linked: 3
- Michael W, 2000, AJPM, 10, 6
- Burrows GT, 1995, Neurology, 45, A187
- Novelli GP, 1998, The Pain Clinic, 11, 5
Cited by
Qaseem, A., Wilt, T. J., McLean, R. M., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m16-2367 · Cited by 3,234
“Low-quality evidence showed no clear differences in adverse effects for ga-bapentin versus placebo (67, 68).”
BackgroundChou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
“Gabapentin is associated with small, short-term benefits in patients with radiculopathy (101, 102) and has not been directly compared with other medications or treatments.”
BackgroundChou, R., Deyo, R., Friedly, J., Skelly, A., Weimer, M., Fu, R., Dana, T., Kraegel, P., Griffin, J., & Grusing, S. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2458 · Cited by 864
“For chronic radicular back pain, 3 poor-quality trials reported inconsistent findings for gabapentin (dose titrated up to 1200 to 3600 mg/d) versus placebo (105, 107, 114).”
BackgroundGabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Chou, R., & Huffman, L. H. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00008 · Cited by 583
“80 patients) trials found gabapentin (2 trials [78], 1 higherquality [77]) and topiramate (1 higher-quality trial [79]) to be associated with small improvements in pain scores compared with placebo (or diphenhydramine as active placebo [79]).”
Background
Metadata
- Authors
- Yildirim, K., Şışecıoğlu, M., Karatay, S., Erdal, A., Levent, A., Uğur, M., & Şenel, K.
- Venue
- The Pain Clinic
- Publisher
- Informa UK Limited
- Published
- 2003-09
- Volume
- 15
- Issue
- 3
- Pages
- 213-218
- ISSN
- 0169-1112 (ISSN-L)
- 1568-5691
- OpenAlex
- W2105755758
- Cited by
- 79
- References
- 18
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 7 · 2013: 3 · 2012: 3
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Pain Clinic (publishedVersion)
- Topics
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Spine and Intervertebral Disc Pathology
- Keywords
- gabapentin, chronic radiculopathy, lumbosciatica, lumbar disc herniation, low back pain, analgesia, motor function, sensory function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effectiveness of gabapentin in patients with chronic radiculopathy. https://app.cochat.ai/papers/10.1163/156856903767650718
- The paper
- Yildirim, K., Şışecıoğlu, M., Karatay, S., Erdal, A., Levent, A., Uğur, M., & Şenel, K. (2003). The effectiveness of gabapentin in patients with chronic radiculopathy. The Pain Clinic. https://doi.org/10.1163/156856903767650718
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.